PHARMATTOU: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMATTOU
Largest movements
- Cash +€23,005
up €23,005 (+20.6%), from €111,666 to €134,672
mainly Net result for the year (+€28,691) and Depreciation (+€581)
- Profit (loss) carried forward +€28,691
up €28,691 (+31.9%), from €89,984 to €118,675
- Other debts -€7,537
down €7,537 (-53.9%), from €13,976 to €6,439
- Gross operating margin -€13,876
down €13,876 (-26.4%), from €52,582 to €38,707
- Taxes -€2,672
down €2,672 (-24.0%), from €11,151 to €8,479
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €124,682 | €146,566 | +€21,884 | +17.6% |
| Fixed assets | 21/28 | €698 | €118 | -€581 | -83.1% |
| Tangible fixed assets | 22/27 | €698 | €118 | -€581 | -83.1% |
| Furniture and vehicles | 24 | €698 | €118 | -€581 | -83.1% |
| Current assets | 29/58 | €123,984 | €146,449 | +€22,465 | +18.1% |
| Amounts receivable within one year | 40/41 | €12,145 | €11,694 | -€451 | -3.7% |
| Trade receivables | 40 | €12,145 | €11,694 | -€451 | -3.7% |
| Cash at bank and in hand | 54/58 | €111,666 | €134,672 | +€23,005 | +20.6% |
| Deferred charges and accrued income | 490/1 | €172 | €83 | -€89 | -51.8% |
| Total equity and liabilities | 10/49 | €124,682 | €146,566 | +€21,884 | +17.6% |
| Equity | 10/15 | €91,984 | €120,675 | +€28,691 | +31.2% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €89,984 | €118,675 | +€28,691 | +31.9% |
| Amounts payable | 17/49 | €32,698 | €25,891 | -€6,806 | -20.8% |
| Amounts payable within one year | 42/48 | €32,434 | €25,891 | -€6,542 | -20.2% |
| Trade debts | 44 | €867 | €1,359 | +€493 | +56.8% |
| Suppliers | 440/4 | €867 | €1,359 | +€493 | +56.8% |
| Taxes, remuneration and social security | 45 | €17,591 | €18,093 | +€502 | +2.9% |
| Taxes | 450/3 | €15,391 | €18,093 | +€2,702 | +17.6% |
| Remuneration and social security | 454/9 | €2,200 | - | -€2,200 | |
| Other amounts payable | 47/48 | €13,976 | €6,439 | -€7,537 | -53.9% |
| Accrued charges and deferred income | 492/3 | €264 | - | -€264 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €579 | €581 | +€1 | +0.2% |
| Other operating charges | 640/8 | €611 | €773 | +€161 | +26.4% |
| Gross operating margin | 9900 | €52,582 | €38,707 | -€13,876 | -26.4% |
| Operating profit (loss) | 9901 | €51,392 | €37,354 | -€14,038 | -27.3% |
| Financial income | 75/76B | - | €16 | +€16 | |
| Recurring financial income | 75 | - | €16 | +€16 | |
| Financial charges | 65/66B | €167 | €199 | +€33 | +19.7% |
| Recurring financial charges | 65 | €167 | €199 | +€33 | +19.7% |
| Profit (loss) for the period before taxes | 9903 | €51,225 | €37,170 | -€14,055 | -27.4% |
| Income taxes | 67/77 | €11,151 | €8,479 | -€2,672 | -24.0% |
| Profit (loss) for the period | 9904 | €40,074 | €28,691 | -€11,383 | -28.4% |
| Profit (loss) for the period to be appropriated | 9905 | €40,074 | €28,691 | -€11,383 | -28.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.